Global Enteral Nutrition Market Is Estimated To Witness High Growth Owing To Abbott Laboratories and Nestlé S.A.

Enteral nutrition market
 Enteral nutrition market


 

The global Enteral nutrition market is estimated to be valued at US$2,635.9 million in 2020 and is expected to exhibit a CAGR of 5.8% over the forecast period 2020-2027.

 

A) Market Overview:

Enteral nutrition refers to the delivery of nutrients directly into the digestive tract, bypassing the oral route. It is typically used for patients who cannot consume normal food or have difficulty absorbing nutrients. Enteral nutrition products include formulas that provide complete nutrition, such as proteins, carbohydrates, fats, vitamins, and minerals. These products are commonly used in hospitals, nursing homes, and homecare settings.

 

B) Market Dynamics:

1. Increasing prevalence of chronic diseases: The rising prevalence of chronic diseases such as cancer, diabetes, and gastrointestinal disorders drives the demand for enteral nutrition. These patients often experience difficulty in eating or have malabsorption issues, making enteral nutrition a crucial part of their treatment.

 

2. Growing geriatric population: The aging population is prone to various health issues and often faces difficulty in consuming regular meals. As the geriatric population continues to grow, the demand for enteral nutrition products is expected to increase.

 

The global Enteral Nutrition Market Growth is expected to witness high growth, exhibiting a CAGR of 5.8% over the forecast period.

 

C) SWOT Analysis:

Strength:

1. Convenient mode of nutrition delivery: Enteral nutrition products offer a convenient and effective way to provide essential nutrients to patients who cannot consume regular food. This method ensures adequate nutrition intake and supports patient recovery.

 

2. High demand in hospitals and healthcare facilities: Hospitals and healthcare facilities are the primary end-users of enteral nutrition products. The demand for these products remains high in these settings, creating a stable market.

 

Weakness:

1. Limited awareness in some regions: Despite the growing popularity of enteral nutrition, there is still limited awareness in certain regions. This can hinder market growth in these areas.

 

2. High cost of enteral nutrition products: Enteral nutrition products can be expensive, especially for long-term use. This may limit their affordability and accessibility for some patients.

 

Opportunity:

1. Technological advancements in enteral pumps and feeding tubes: Ongoing advancements in enteral pumps and feeding tubes improve the efficiency and safety of enteral nutrition delivery. This presents an opportunity for market players to develop innovative products and gain a competitive edge.

 

2. Growing homecare market: The increasing trend of treating patients at home rather than in hospitals creates a significant opportunity for the enteral nutrition market. Homecare settings often rely on enteral nutrition for patients who require long-term or continuous nutritional support.

 

Threats:

1. Stringent regulations and safety concerns: The enteral nutrition market is subject to strict regulations and safety standards due to the risk of complications such as tube dislodgement and infection. Adhering to these regulations can pose challenges for market players.

 

2. Competition from parenteral nutrition: Parenteral nutrition, which involves delivering nutrients through intravenous methods, is an alternative to enteral nutrition. The competition between enteral and parenteral nutrition products may impact market growth.

 

D) Key Takeaways:

 

North America is the dominating region in the enteral nutrition market, driven by the presence of key players such as Abbott Laboratories and Nestlé S.A. The region also has a well-established healthcare infrastructure and a high prevalence of chronic diseases.

 

Other key players operating in the global enteral nutrition market include Danone S.A., Fresenius Kabi AG, Mead Johnson & Company, LLC, B. Braun Melsungen AG, Otsuka Pharmaceutical Co., Ltd, Meiji Holdings Co., Ltd., Bahrain Pharma, Bionova Lifesciences, Global Health Products Inc., Victus Inc., and Curtis Health Caps SP.

1.    Overall, the enteral nutrition market is poised for significant growth due to the increasing prevalence of chronic diseases and the growing geriatric population. Technological advancements and the expanding homecare market are also expected to drive market growth. However, strict regulations and competition from parenteral nutrition pose challenges for market players.

Post a Comment

Previous Post Next Post